{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:59:14Z","timestamp":1792609154025,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.leukres.2009.08.032","type":"journal-article","created":{"date-parts":[[2009,10,5]],"date-time":"2009-10-05T13:36:12Z","timestamp":1254749772000},"page":"708-713","source":"Crossref","is-referenced-by-count":5,"title":["Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving dasatinib"],"prefix":"10.1016","volume":"34","author":[{"given":"Ronald L.","family":"Paquette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Nicoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenal","family":"Chalukya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Gondek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Jasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Sawyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil P.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2009.08.032_bib1","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"Druker","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.08.032_bib2","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","author":"Deininger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.08.032_bib3","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa055229","article-title":"Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias","volume":"354","author":"Talpaz","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2009.08.032_bib4","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1182\/blood-2006-09-047266","article-title":"Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy","volume":"109","author":"Hochhaus","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.leukres.2009.08.032_bib5","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/cncr.11729","article-title":"Chromosome abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase","volume":"98","author":"Medina","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2009.08.032_bib6","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1182\/blood-2002-07-2053","article-title":"Emergence of clonal cytogenetic abnormalities in Ph\u2212 cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority","volume":"101","author":"Bumm","year":"2003","journal-title":"Blood."},{"key":"10.1016\/j.leukres.2009.08.032_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.leu.2402848","article-title":"Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate","volume":"17","author":"O\u2019Dwyer","year":"2003","journal-title":"Leukemia."},{"key":"10.1016\/j.leukres.2009.08.032_bib8","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2003-06-1943","article-title":"Chromosomal abnormalities in Ph\u2212 cells of patients on imatinib","volume":"102","author":"McMullin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.08.032_bib9","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/sj.leu.2403399","article-title":"Report of 34 patients with clonal chromosomal abnormalities in Philadelphia negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia","volume":"18","author":"Terre","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2009.08.032_bib10","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1080\/10428190410001723278","article-title":"Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib","volume":"45","author":"Loriaux","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2009.08.032_bib11","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/cncr.22936","article-title":"The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in Philadelphia chromosome-negative cells","volume":"110","author":"Deininger","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2009.08.032_bib12","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood-2007-01-070045","article-title":"Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase","volume":"110","author":"Jabbour","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.08.032_bib13","first-page":"127","article-title":"Cytogenetics of myelodysplastic syndromes","volume":"33","author":"Fenaux","year":"1996","journal-title":"Sem Hematol"},{"key":"10.1016\/j.leukres.2009.08.032_bib14","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1182\/blood-2006-04-017400","article-title":"Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia","volume":"108","author":"Kovitz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.08.032_bib15","first-page":"1229","article-title":"Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the androgen-receptor gene correlates with X chromosome inactivation","volume":"51","author":"Allen","year":"1992","journal-title":"Am J Human Genet"},{"key":"10.1016\/j.leukres.2009.08.032_bib16","first-page":"1578","article-title":"Quantitative non-radioactive clonality analysis of human leukemic cells and progenitors using the human androgen receptor (AR) gene","volume":"9","author":"Delabesse","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2009.08.032_bib17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2008-02-130435","article-title":"Whole genome scanning as a cytogenetic tool in hematologic malignancies","volume":"112","author":"Maciejewski","year":"2008","journal-title":"Blood."},{"key":"10.1016\/j.leukres.2009.08.032_bib18","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1182\/blood-2007-03-079673","article-title":"Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndrome","volume":"110","author":"Mohamedali","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.08.032_bib19","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2007-05-092304","article-title":"Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS\/MPD, and MDS-derived AML","volume":"111","author":"Gondek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.08.032_bib20","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1158\/0008-5472.CAN-08-2754","article-title":"250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies","volume":"68","author":"Dunbar","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2009.08.032_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/mcpr.1997.0099","article-title":"Clonal X-inactivation analysis of human tumors using the human androgen receptor gene (HUMARA) polymorphism: a non-radioactive and semiquantitative strategy applicable to fresh and archival tissue","volume":"11","author":"Kopp","year":"1997","journal-title":"Mol Cell Probes"},{"key":"10.1016\/j.leukres.2009.08.032_bib22","first-page":"4806","article-title":"Clonal analysis using recombinant DNA probes from the X-chromosome","volume":"47","author":"Vogelstein","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2009.08.032_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM199407213310303","article-title":"Langerhans\u2019-cell histiocytosis (Histiocytosis X)\u2014a clonal proliferative disease","volume":"331","author":"Willman","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2009.08.032_bib24","doi-asserted-by":"crossref","first-page":"312a","DOI":"10.1182\/blood.V110.11.1030.1030","article-title":"PHA-739358, an Aurora kinase inhibitor, induces clinical responses in chronic myeloid leukemia harboring T315I mutations of BCR\u2013ABL","volume":"110","author":"Paquette","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.08.032_bib25","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3324\/haematol.11064","article-title":"Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib failure","volume":"92","author":"Fabarius","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2009.08.032_bib26","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.leu.2400642","article-title":"Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases","volume":"11","author":"Fayad","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2009.08.032_bib27","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1038\/sj.onc.1202571","article-title":"Determination of cell fate by c-Abl activation in the response to DNA damage","volume":"17","author":"Kharbanda","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2009.08.032_bib28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bbrc.2005.03.152","article-title":"C-Abl as a modulator of p53","volume":"331","author":"Levav-Cohen","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.leukres.2009.08.032_bib29","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1038\/onc.2008.68","article-title":"Pharmacologic inhibition of c-Abl compromises genetic stability and DNA repair in Bcr\u2013Abl-negative cells","volume":"27","author":"Fanta","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2009.08.032_bib30","doi-asserted-by":"crossref","first-page":"875a","DOI":"10.1182\/blood.V112.11.2521.2521","article-title":"SNP array-based analysis of chromosome 17 reveals biallelic TP53 mutations due to uniparental disomy 17p in advanced MDS and AML with cooperating deletions of chromosomes 5 and 7","volume":"112","author":"Jasek","year":"2008","journal-title":"Blood."},{"key":"10.1016\/j.leukres.2009.08.032_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.leukres.2007.06.022","article-title":"Identification of a novel, transactivation-defective splicing variant of p53 gene in patients with chronic lymphocytic leukemia","volume":"32","author":"Pekova","year":"2008","journal-title":"Leukemia Res"},{"key":"10.1016\/j.leukres.2009.08.032_bib32","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood.V91.2.616","article-title":"Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion","volume":"91","author":"Sterkers","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.08.032_bib33","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1365-2141.1996.d01-1690.x","article-title":"p53 tumour suppressor gene and RAS oncogenes: molecular analysis in the chronic and leukaemic phases of essential thrombocythaemia","volume":"93","author":"Neri","year":"1996","journal-title":"Br J Haematol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609004391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609004391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T19:54:13Z","timestamp":1590177253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212609004391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0145212609004391"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2009.08.032","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}